Skip to content

GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT231212Recalls & reported problems

W. L. Gore & Associates, Inc. · EXCLUDER CONFORM AAA TRNK ENDO 23mmX12mmX12cm 15Fr · Class 3 · Implant

All models of GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral (10)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00733132651009), received between Jan 17, 2023 and Aug 15, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Obstruction of Flow” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Obstruction of Flow1
  • Partial Blockage1
  • Patient-Device Incompatibility1

Patient problems

  • Thrombosis/Thrombus2
  • Inflammation1
  • Obstruction/Occlusion1
  • Pain1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2021, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESES (CEXC). THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2025, THE PATIENT UNDERWENT REINTERVENTION TO TREAT A THROMBOSED LEFT LIMB OF THE CEXC DEVICE. THE PHYSICIAN CHOSE TO MAKE THE CEXC INTO AN AORTO-UNI-ILIAC (AUI) BY PLACING A GORE® EXCLUDER® CONTRALATERAL LEG COMPONENT (PLC231200) INVERTED WITH THE 23MM END AT THE RENAL ARTERIES WITH THE 16MM DIAMETER DISTAL END IN THE RIGHT LIMB. THE PHYSICIAN THEN DID A FEM-FEM BYPASS TO PROVIDE FLOW FROM THE RIGHT COMMON FEMORAL TO THE LEFT COMMON FEMORAL. THE PATIENT TOLERATED THE PROCEDURE.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 22822307 ↗
  • InjuryMar 4, 2024Obstruction of Flow; Patient-Device Incompatibility; Obstruction of Flow; Patient-Device Incompatibility

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2023, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ANEURYSM USING THE GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS AND 3 GORE® EXCLUDER® AAA ENDOPROSTHESIS. ON (B)(6) 2024, THE PATIENT HAD THROMBUS. BOTH OF THEIR EXTERNAL ILIACS THROMBOSED AND A CLOT WENT NORTH. THEIR SYSTEM WAS OCCLUDED. THE PHYSICIAN HAS NOT RE-INTERVENED; HOWEVER, THEY ARE PLANNING NEXT STEPS. THEY WILL POSSIBLY PERFORM AN AXILLA-FEMORAL BYPASS. AS OF NOW, THE PATIENT IS STABLE. THE PHYSICIAN SUSPECTED THAT THE PATIENT HAD A CLOTTING DISORDER AND CLOTTED THE LEFT EXTERNAL ILIAC AND IT CONTINUED PROXIMAL INTO THE EXCLUDER.

    Patient problems: Obstruction/Occlusion; Thrombosis/Thrombus

    MAUDE report 18827184 ↗
  • InjuryJan 17, 2023Partial Blockage; Partial Blockage

    THE FOLLOWING WAS REPORTED TO GORE: PATIENT HAD AN OCCLUDED LEFT LIMB. THIS WAS OCCLUDED FROM THE TOP OF THE BIFURCATION TO THE LEFT HYPOGASTRIC ARTERY. THERE WAS A NARROWING IN THE VBX DEVICE WHICH WAS IMPLANTED IN THE LEFT COMMON ILIAC ARTERY (CIA). THE INITIAL IMPLANT ON DEC. 16 WAS WITH A PLL161007 ABOVE THE LCIA AND HAD AN EXTENSION OF A 8L X79. THROMBECTOMY CATHETER WAS USED AND OPENED VESSEL AND THAN WE USED KISSING 8L STENTS JUST ABOVE FLOW DIVIDER TO RESTORE FLOW. PATIENT DOING WELL.

    Patient problems: Inflammation; Pain

    MAUDE report 16184324 ↗

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page